| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B | $0.9B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.0B | $0.0B |
| Net Income | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $15.64 | $13.06 | $9.20 | $7.57 | $5.06 | $4.07 | $0.82 | $0.64 |
| EPS (Diluted) | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 | $3.84 | $0.78 | $0.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0B | $2.1B | $1.7B | $1.4B | $1.7B | $1.4B | $1.1B | $1.0B |
| Current Assets | $1.0B | $1.0B | $0.6B | $0.3B | $0.7B | $0.5B | $0.3B | $0.2B |
| Cash & Equivalents | $0.5B | $0.7B | $0.2B | $0.0B | $0.5B | $0.3B | $0.1B | $0.0B |
| Total Liabilities | $1.5B | $1.3B | $1.1B | $1.0B | $0.7B | $0.6B | $0.4B | $0.4B |
| Current Liabilities | $1.3B | $1.1B | $0.9B | $0.8B | $0.6B | $0.4B | $0.3B | $0.3B |
| Stockholders' Equity | $0.5B | $0.8B | $0.6B | $0.4B | $1.0B | $0.8B | $0.7B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.9B | $-0.2B | $-0.2B | $-0.8B | $-0.0B | $-0.1B | $-0.1B | $-0.1B |